Kadmon Corporation, LLC
Records under this name other than the patents Kadmon Corporation, LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 24 patents it holds.
Showing 1 to 8 of 8 · Back to Kadmon Corporation, LLC
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,494,646 | Regulation of Gene Expression by Aptamer-Mediated Modulation of Alternative Splicing Formerly held In force · High confidence | In force | High confidence | |
| US 12,359,199 | Regulation of gene expression via aptamer-mediated control of self-cleaving ribozymes Formerly held In force · USPTO record | In force | USPTO record | |
| US 11,512,310 | Regulation of gene expression via aptamer-mediated control of self-cleaving ribozymes Formerly held In force · USPTO record | In force | USPTO record | |
| US 11,697,815 | Regulation of Gene Expression Through Aptamer-Modulated Polyadenylation Formerly held In force · High confidence | In force | High confidence | |
| US 10,080,752 | Treatment of Brain and Central Nervous System Tumors Lapsed on the fee record Ended Sep 25, 2026 · High confidence | Lapsed on the fee record | Ended Sep 25, 2026 | High confidence |
| US 9,586,940 | Methods for Treatment of Breast Cancer Nonresponsive to Trastuzumab Lapsed on the fee record Ended Mar 7, 2021 · Medium confidence | Lapsed on the fee record | Ended Mar 7, 2021 | Medium confidence |
| US 8,338,481 | Alkoxyalkyl S-Prenylthiosalicylates for Treatment of Cancer Lapsed on the fee record Ended Dec 25, 2020 · High confidence | Lapsed on the fee record | Ended Dec 25, 2020 | High confidence |
| US 8,088,756 | Methods and Compositions for Oral Delivery of FTS Held by another company Lapsed on the fee record Ended Jan 3, 2020 · High confidence | Lapsed on the fee record | Ended Jan 3, 2020 | High confidence |